In HCC, sustained Nuclear erythroid 2-related factor 2 (Nrf2) activation, which is a cytosolic transcription factor that acts against oxidative stress, leads to cellular proliferation and resistance to drugs. Here, NFE2L2 is linked to hepatocellular carcinoma.